Breaking News

Shire To Supply Generic Adderall XR

December 2, 2013

Sandoz to market authorized generic in the U.S.

Shire’s subsidiary, Shire US Inc., has entered an agreement with Sandoz to supply an authorized generic version of its product Adderall XR. Sandoz will market the authorized generic beginning July 1, 2016. Sandoz has agreed to exclusively sell the authorized generic supplied by Shire from December 1, 2013 through the end of the agreement's five-year term. 
 
Shire will manufacture and supply all dosage strengths of the authorized generic product and Sandoz will distribute the product in the U.S. Shire will receive royalties on sales of the product.

blog comments powered by Disqus
  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • CMOs: A Flexibility Alternative

    CMOs: A Flexibility Alternative

    Philip K. Burns, CRO-Consulting||January 28, 2016
    A look at how to include CMOs as an option to improve overall flexibility

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.